DYNE THERAPEUTICS INC
29.81
06-November-24 14:59:57
15 minutes delayed
Stocks
+1.19
+4.16%
Today's range
29.31 - 30.43
ISIN
N/A
Source
NASDAQ
-
16 May 2022 06:30:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics Reports First Quarter 2022 Financial Results and Business Highlights
02 May 2022 15:05:01 By Nasdaq GlobeNewswire
-
Dyne Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Highlights
10 Mar 2022 06:30:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics Appoints Carlo Incerti, M.D., to its Board of Directors
03 Mar 2022 06:30:00 By Nasdaq GlobeNewswire
-
18 Jan 2022 07:00:01 By Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
05 Jan 2022 06:30:00 By Nasdaq GlobeNewswire
-
02 Dec 2021 07:30:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics Reports Third Quarter 2021 Financial Results and Business Highlights
04 Nov 2021 06:30:01 By Nasdaq GlobeNewswire
-
13 Oct 2021 06:45:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics to Host Virtual Research and Development Day on Wednesday, October 13, 2021
28 Sep 2021 06:30:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Chardan’s Virtual 5th Annual Genetic Medicines Conference
27 Sep 2021 06:30:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics Reports Second Quarter 2021 Financial Results and Business Highlights
05 Aug 2021 06:30:01 By Nasdaq GlobeNewswire
-
25 Jun 2021 06:30:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics Announces Chief Scientific Officer Transition
02 Jun 2021 15:05:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Jefferies Virtual Healthcare Conference
26 May 2021 06:30:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics Reports First Quarter 2021 Financial Results and Business Highlights
06 May 2021 06:29:00 By Nasdaq GlobeNewswire